🔻 SUNPHARMA tested the VRZ Low, with sellers attempting to extend the downside below the support zone.
🚨 Price struggled to sustain below the VRZ Low and showed a sharp rejection from the lower levels.
🟢 The recovery above the support zone confirmed the Breakdown Failure (BOF) structure and initiated a bullish reversal.
🟢 Buyers stepped in after the failed breakdown and pushed SUNPHARMA higher from the VRZ Low.
📊 The recovery around ₹1,820.00 highlighted a shift in short-term price action.
🚀 The setup ultimately delivered a 1.53% bullish move with a 1:4 Risk-Reward.
🔴 Sellers: Attempted to extend the breakdown below the VRZ Low.
🟡 Breakdown Traders: Faced pressure as price rejected the lower zone.
🟢 Buyers: Regained control and drove the bullish recovery.
🎭 The initial downside move created bearish pressure around the support zone.
⚠️ However, sellers failed to sustain the breakdown.
📈 The strong rejection and subsequent recovery shifted momentum toward buyers.
🎯 The key confirmation came when SUNPHARMA rejected the ₹1,820.00 VRZ Low and recovered above the zone.
🔄 The failed breakdown indicated weakening selling pressure.
⚡ Strong bullish follow-through validated the developing BOF structure.
🔸 🚫 Failed Breakdown Can Trap Sellers
When price fails to sustain below support, breakdown positions can come under pressure.
🔹 🎯 VRZ Low Rejection
The ₹1,820.00 zone provided an important technical reference for the reversal.
🛡️ Defined Risk Supports Trade Discipline
The VRZ Low offered a clear reference for managing trade risk.
⚡ 📈 Strong Recovery Momentum
The sharp recovery following the rejection helped establish bullish momentum.
📈 After rejecting the VRZ Low, SUNPHARMA developed a stronger intraday recovery structure.
🟢 Buyers maintained control as price moved away from the support zone.
🚀 The improving price action supported the continuation of the upside move.
🔥 Buying momentum accelerated following the breakdown failure.
📈 SUNPHARMA recovered strongly from the VRZ Low and extended the bullish move.
🏆 The setup delivered a 1.53% upside move with 1:4 RR.
🔸 The setup became actionable after SUNPHARMA failed to sustain below the ₹1,820.00 VRZ Low.
📈 Buyers reclaimed the support zone and established bullish control.
⚖️ The confirmed BOF structure provided a defined-risk intraday setup with a 1:4 Risk-Reward.
